ask="18.10"
ask_size="100"
average_daily_volume="278528"
bid="18.02"
bid_size="1000"
book_value="3.21"
change="+0.01"
change_from_200_day_moving_average="5.95"
change_from_50_day_moving_average="1.69"
change_from_52_week_high="-4.95"
change_From_52_week_low="13.48"
change_in_percent="+0.06%"
close="18.12"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.61"
eps_estimate_next_quarter="-0.71"
eps_estimate_next_year="-2.64"
ex_dividend_date="N/A"
float_shares="6537000"
high="18.59"
high_52_weeks="23.07"
last_trade_date="1/20/2017"
last_trade_price="18.12"
last_trade_size="3556"
last_trade_time="4:00pm"
low="18.01"
low_52_weeks="4.64"
market_capitalization="180.35M"
moving_average_200_day="12.17"
moving_average_50_day="16.43"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.43"
open="18.40"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+48.95%"
percent_change_from_50_day_moving_average="+10.25%"
percent_change_from_52_week_high="-21.45%"
percent_change_from_52_week_low="+290.52%"
previous_close="18.11"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.65"
price_per_sales="3188.89"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="8.35"
stock_exchange="NGM"
symbol="ZYNE"
volume="446682"
weeks_range_52="4.64 - 23.07"
